Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence
Premier journal of science. December 3, 2024 Kanwal Shabir
Microdosing psilocybin—taking very small, sub-hallucinogenic doses—may help relieve anxiety in young adults. A systematic review of studies published between 2014 and 2024 found that microdosing is associated with improved mood, reduced anxiety symptoms, and enhanced emotional resilience and mental well-being. The compound appears to work by modulating serotonin receptors, promoting neural plasticity, and improving connectivity in brain regions involved in emotional regulation. Short-term benefits include increased focus and cognitive flexibility; long-term effects may involve sustained anxiety reduction and better overall mental health. However, variability in study designs and dosing regimens underscores the need for standardized protocols and further research on long-term safety and efficacy.